Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation
Daniel H. Fowler, Miriam E. Mossoba, Seth M. Steinberg, David C. Halverson, David Stroncek, Hahn M. Khuu, Frances T. Hakim, Luciano Castiello, Marianna Sabatino, Susan F. Leitman, Jacopo Mariotti, Juan C. Gea-Banacloche, Claude Sportes, Nancy M. Hardy, Dennis D. Hickstein, Steven Z. Pavletic, Scott Rowley, Andre Goy, Michele Donato, Robert KorngoldAndrew Pecora, Bruce L. Levine, Carl H. June, Ronald E. Gress, Michael R. Bishop
Dive into the research topics of 'Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation'. Together they form a unique fingerprint.